Home » News

Latest News from AAAP

Changing news
about changing lives.

November 9, 2023
The American Academy of Addiction Psychiatry (AAAP) and the American Society of Addiction Medicine (ASAM) have jointly developed a crucial Clinical Practice Guideline on the Management of Stimulant Use Disorder (StUD). This groundbreaking guideline is designed to provide evidence-based strategies and clinically informed standards of care for the prevention and treatment of StUD, stimulant intoxication, and stimulant withdrawal.
July 11, 2023
As Congressionally-mandated, medical practitioners have a new role to help patients fighting to sustain recovery and prevent opioid overdoses. All medical registrants submitting a new or renewing a current registration must attest to completing an eight-hour training to treat patients overcoming opioid and other substance use disorders.
March 29, 2023
WASHINGTON, D.C. – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued a statement following the U.S. Food and Drug Administration (FDA) approval of the first nonprescription, “over-the-counter” (OTC) Naloxone nasal spray (Narcan). Naloxone – a medicine that can reverse an opioid-related overdose – has been shown to be a critical tool to prevent fatal overdoses and save lives.
March 27, 2023
PCSS wanted to share this email from the federal Drug Enforcement Agency regarding new training requirements.
March 10, 2023
“Based on current COVID-19 trends, the Department of Health and Human Services is planning for the federal Public Health Emergency for COVID-19 (PHE), declared under Section 319 of the Public Health Service Act, to expire at the end of the day on May 11, 2023. Thanks to the Administration’s whole-of-government approach to combatting the virus, we are in a better place in our response than we were three years ago, and we can transition away from an emergency phase.”

Be in the know. Become an AAAP Member today.

Discover The American Journal on Addictions